Anna Richardson

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Katrina Moore, Jennifer Nicholas, Murray Grossman et al. · The Lancet Neurology · 2019 · 311 citations · Full text

Medicine, Genetics, Neurology +17

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Neurology, Pharmacology +17

Functional Consequences of a Polymorphism Affecting NF-κB p50-p50 Binding to the <i>TNF</i> Promoter Region

Irina A. Udalova, Anna Richardson, A Denys et al. · Molecular and Cellular Biology · 2000 · 209 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria

Andrew E. Fry, Michael J. Griffiths, Sarah Auburn et al. · Human Molecular Genetics · 2007 · 191 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 191 citations · Full text

Medicine, Neurology, Pharmacotherapy +15